Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Diabet Med. 2015 Jan 7;32(5):657–664. doi: 10.1111/dme.12664

FIGURE 2.

FIGURE 2

Effect of treatment with placebo or muraglitazar on plasma total adiponectin. †P < 0.01 for the comparison between muraglitazar and placebo therapy-treated groups. Data are shown as means ± se.